Viewing Study NCT02226458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-02-22 @ 3:56 PM
Study NCT ID: NCT02226458
Status: WITHDRAWN
Last Update Posted: 2022-01-21
First Post: 2014-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Sponsor: Edison Pharmaceuticals Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autism Spectrum Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Autism View
None Mitochondrial Disorders View
None EPI-743 View
None EPI743 View
None Rett syndrome View
None Angelman syndrome View